Latest From Biotech Now

Tackling the Thorny Problem of Alzheimer’s


Football fans are gearing up for tonight’s opening game when the defending Champion Seattle Seahawks take on the Green Bay Packers, and last minute fantasy leaguers are scrambling to finish their drafts and set their starting line-ups. The NFL has also been in the news recently following preliminary approval of a deal in the class-action lawsuit to compensate former players for concussion-related injury claims. According to a 2012 study in Neurology, NFL players are three Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Pennsylvania Roundtable Answers the Call for Cures

Collins and Greenwood-115x76

Congressman Joe Pitts (PA-16) recently hosted a roundtable in Lancaster to discuss how to expedite cures and treatments with leading national, regional and local health care innovators from the government, private, and public sectors, including BIO’s Jim Greenwood, Dr. Francis Collins, Director of the National Institutes of Health, and Dr. Margaret Hamburg, Commissioner for the U.S. Food and Drug Administration. The roundtable is one of many being held across the country as part of the Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

The New Republic: We are Entering the Age of Alzheimer’s


The New Republic this week published a lengthy, powerful piece by Kent Russell on Alzheimer’s. Russell opens the piece by noting that we are approaching a public health crisis in Alzheimer’s and dementia: Alzheimer’s disease is practically unheard of in adults younger than 40, and very rare (one in 2,500) for those under 60. It affects 1 percent of 65-year-olds, 2 percent of 68-year-olds, 3 percent of 70-year-olds. After that, the odds start multiplying. The Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Roadblocks and Red Tape Block Search for Cures

scientist, lab

Since its passage more than two years ago, the JOBS Act has spurred more than 110 biotech IPOs. And now the SEC is in the process of finalizing another important piece of the law that could further encourage biotech capital formation. The JOBS Act directs the SEC to raise the offering ceiling under Regulation A – a securities law exemption that allows companies to raise public capital with a reduced reporting burden – from $5 Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Pro-GMO Labeling Business Faces Own Labeling Dilemma


 “Dr. Bronner’s should spend more time worrying about their own labels.” The Center for Consumer Freedom recently published an interesting piece on Dr. Bronner’s Magic Soaps and his run in with the FDA.  You may know that Dr. Bronner’s Magic Soaps is an outspoken advocate of the scientifically suspect “GMO labeling” movement.  In a warning letter to the company, the FDA states: “Based on our review of the product label, we have determined that your product is promoted for conditions that Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,